Arix Bioscience’s portfolio company Imara Inc to merge with Enliven Therapeutics
LONDON, UK: Arix Bioscience plc (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, notes that its portfolio company, Imara Inc. has entered into a definitive merger agreement with Enliven Therapeutics Inc. to create a…